Medgend Icon







discontinued


Betamethasone Dipropionate FDA Approved Drugs

BETAMETHASONE DIPROPIONATE [Betamethasone DipropionateC28H37FO7]
RX
-
eq 0.05% base (topical ointment, augmented)
Actavis Mid AtlanticAug 31, 1995
FougeraSep 4, 1984
Fougera PharmsDec 9, 2003
Fougera Pharms IncAug 12, 1985
G And W Labs IncAug 10, 1987
Glenmark GenericsSep 23, 2008
Perrigo New YorkDec 9, 2003
TaroApr 30, 1992
TolmarJan 23, 2004
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE [Betamethasone DipropionateC28H37FO7 : Calcipotriene HydrateC27H40O3H2O]
RX
-
0.064% : 0.005% (topical ointment)
Perrigo IsraelDec 12, 2014
TolmarJan 14, 2013
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE [Betamethasone DipropionateC28H37FO7 : ClotrimazoleC22H17ClN2]
RX
-
eq 0.05% base : 1% (topical cream)
Actavis Mid AtlanticAug 2, 2002
Fougera PharmsJun 16, 2005
Glenmark PharmsOct 30, 2015
TaroJul 28, 2004
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIPROLENE [Betamethasone DipropionateC28H37FO7]
RX
-
eq 0.05% base (topical lotion, augmented)
Merck Sharp DohmeAug 1, 1988
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIPROLENE AF [Betamethasone DipropionateC28H37FO7]
RX
-
eq 0.05% base (topical cream, augmented)
Merck Sharp DohmeApr 27, 1987
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ENSTILAR [Betamethasone DipropionateC28H37FO7 : CalcipotrieneC27H40O3]
RX
-
0.064% : 0.005% (topical aerosol, foam)
Leo Pharma AsOct 16, 2015
  • Plaque psoriasis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LOTRISONE [Betamethasone DipropionateC28H37FO7 : ClotrimazoleC22H17ClN2]
RX
-
eq 0.05% base : 1% (topical lotion)
Merck Sharp DohmeDec 8, 2000
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SERNIVO [Betamethasone DipropionateC28H37FO7]
RX
-
eq 0.05% base/spray (topical spray)
Promius Pharma LlcFeb 5, 2016
  • Treatment of plaque psoriasis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TACLONEX [Betamethasone DipropionateC28H37FO7 : Calcipotriene HydrateC27H40O3H2O]
RX
-
0.064% : 0.005% (topical ointment)
Leo Pharma AsJan 9, 2006
  • Psoriasis.
  • Treatment of moderate plaque psoriasis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.